News Anklam Extrakt® declaration of consent to the newsletter subscription
Our free newsletter keeps you up to date with everything currently happening in our company. I consent to Anklam Extrakt GmbH sending me a newsletter from time to time, to the specified e-mail address. My personal data (surname, first name, e-mail address) may be stored and used/processed for customer communication by Anklam Extrakt GmbH. We use rapidmail to distribute our newsletter. For this reason, your data are transmitted to rapidmail GmbH. rapidmail GmbH is prohibited from using your data for any other purposes than distributing the newsletter. rapidmail GmbH is prohibited from disclosing or selling your data. With each newsletter, you are given the option of cancelling your subscription. In addition, you have the right to request deletion of all your data and restriction of data processing under certain conditions. For further details click here.
New clinical study on Delphinol® for beauty from within
ISO 22000 certificate granted
New clinical study - cognitaven® for cognitive performance
MaquiBright.de goes live
Publication of new study on Delphinol® in regards to Bone Health
Anklam Extrakt® wins NutraIngredients Award 2019 for optibright®
optibright® - Finalist of the NutraIngredients Award for "Omega-3 Product of the Year"
Science News | Maquiberry Extract
Anklam Extrakt® at SupplySide West 2018 in Las Vegas
C² PHARMA and ANKLAM EXTRAKT® announce R&D collaboration to develop cannabidiol-based compounds
ANKLAM EXTRAKT wants to say thank you!
ANKLAM EXTRAKT goes Vitafoods Europe 2018